D. Mais

A. Hogue, E. Vajda, William Y. Chang, 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Binding of thromboxane A2/prostaglandin H2 agonists to human platelets

P. Halushka, P. Kochel, D. Mais, 1987, British journal of pharmacology.

The affinities of prostaglandin H2 and thromboxane A2 for their receptor are similar in washed human platelets.

J. Gillard, P. Halushka, T. Morinelli, 1988, Biochemical and biophysical research communications.

Novel series of potent, nonsteroidal, selective androgen receptor modulators based on 7H-[1,4]oxazino[3,2-g]quinolin-7-ones.

Dale E Mais, James P Edwards, J. Edwards, 2007, Journal of medicinal chemistry.

Localization of ATP sensitive potassium channels in the rat brain using a novel radioligand, [125I]iodoglibenclamide.

J. Krushinski, D. Robertson, D. Gehlert, 1990, European journal of pharmacology.

Quantitative autoradiography of the binding sites for [125I] iodoglyburide, a novel high-affinity ligand for ATP-sensitive potassium channels in rat brain.

D. Robertson, D. Gehlert, D. Mais, 1991, The Journal of pharmacology and experimental therapeutics.

Conversion of human-selective PPARalpha agonists to human/mouse dual agonists: a molecular modeling analysis.

R. Babine, K. Ogilvie, L. L. Winneroski, 2004, Bioorganic & medicinal chemistry letters.

5-Aryl-1,2-dihydrochromeno[3,4-f]quinolines: a novel class of nonsteroidal human progesterone receptor agonists.

M. Gottardis, E. Kallel, T. K. Jones, 1998, Journal of medicinal chemistry.

5-Alkyl 1,2-dihydrochromeno[3,4-f]quinolines: a novel class of nonsteroidal progesterone receptor modulators.

J. Edwards, M. Gottardis, T. K. Jones, 1998, Bioorganic & medicinal chemistry letters.

Synthesis and biological activity of 5-methylidene 1,2-dihydrochromeno[3,4-f]quinoline derivatives as progesterone receptor modulators.

J. Edwards, B. Pio, T. K. Jones, 2003, Bioorganic & medicinal chemistry letters.

Development of dual-acting agents for thromboxane receptor antagonism and thromboxane synthase inhibition. 3. Synthesis and biological activities of oxazolecarboxamide-substituted omega-phenyl-omega-(3-pyridyl)alkenoic acid derivatives and related compounds.

J. Wikel, K. Takeuchi, J. A. Jakubowski, 1998, Journal of medicinal chemistry.

Development of dual-acting agents for thromboxane receptor antagonism and thromboxane synthase inhibition. 2. Design, synthesis, and evaluation of a novel series of phenyl oxazole derivatives.

K. Takeuchi, J. A. Jakubowski, D. Mais, 1998, Bioorganic & medicinal chemistry letters.

Nonsteroidal 2,3-dihydroquinoline glucocorticoid receptor agonists with reduced PEPCK activation.

Steven L. Roach, Lino J Valdez, D. Rungta, 2011, Bioorganic & medicinal chemistry letters.

A tissue-selective nonsteroidal progesterone receptor modulator: 7,9-difluoro-5-(3-methylcyclohex-2-enyl)-2,2,4-trimethyl-1,2-dihydrochromeno[3,4-f]quinoline.

M. Groen, D. Mais, P. Verbost, 2008, Journal of medicinal chemistry.

Synthesis and characterization of nonsteroidal glucocorticoid receptor modulators for multiple myeloma.

Dale E Mais, W. Lamph, E. Kallel, 2007, Journal of medicinal chemistry.

Synthesis and evaluation of [125 I]-(S)-iodozacopride , a high affinity radioligand for 5HT3 receptors

D. Robertson, D. Gehlert, D. Mais, 1993, Neurochemistry International.

Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells.

M. Boehm, R. Heyman, A. Nadzan, 1995, Journal of medicinal chemistry.

Determination of serotonin, its precursors, metabolites and [3H] serotonin in lung by high-performance liquid chromatography with fluorescence detection.

D. Mais, T. Bosin, P. Lahr, 1981, Journal of chromatography.

Synthesis and structure-activity relationships of novel retinoid X receptor-selective retinoids.

L Zhang, Lin Zhang, M. Boehm, 1994, Journal of medicinal chemistry.

Subcellular localization of a thromboxane A2/prostaglandin H2 receptor antagonist binding site in human platelets.

P. Halushka, D. Mais, S. Pepkowitz, 1988, Biochemical pharmacology.

5-Aryl-1,2-dihydro-5H-chromeno[3,4-f]quinolines as potent, orally active, nonsteroidal progesterone receptor agonists: the effect of D-ring substituents.

J. Edwards, M. Gottardis, T. K. Jones, 1998, Journal of Medicinal Chemistry.

Development of progesterone receptor antagonists from 1,2-dihydrochromeno[3,4-f]quinoline agonist pharmacophore.

J. Edwards, B. Pio, T. K. Jones, 2003, Bioorganic & medicinal chemistry letters.

5-Aryl-1,2,3,4-tetrahydrochromeno[3,4-f]quinolin-3-ones as a novel class of nonsteroidal progesterone receptor agonists: effect of A-ring modification.

T. K. Jones, D. Mais, C. Tegley, 1999, Journal of medicinal chemistry.

Nonsteroidal progesterone receptor antagonists based on a conformationally-restricted subseries of 6-aryl-1,2-dihydro-2,2,4-trimethylquinolines.

J. Edwards, L. Hamann, M. Goldman, 1998, Bioorganic & medicinal chemistry letters.

In vitro characterization of a novel TXA2/PGH2 receptor ligand (S-145) in platelets and vascular and airway smooth muscle.

J. A. Jakubowski, G. Dubé, D. Mais, 1992, The Journal of pharmacology and experimental therapeutics.

Development of dual-acting agents for thromboxane receptor antagonism and thromboxane synthase inhibition--I. Synthesis, structure-activity relationship, and evaluation of substituted omega-phenyl-omega-(3-pyridyl)alkenoic acids.

K. Takeuchi, J. A. Jakubowski, D. Mais, 1994, Bioorganic & medicinal chemistry.

Ryanodine and an iodinated analog: doxorubicin effects on binding and Ca2+ accumulation in cardiac sarcoplasmic reticulum.

D. Mais, A. M. Watanabe, N. Bowling, 1994, European journal of pharmacology.

Novel synthesis and biochemical properties of an [125I]-labeled photoaffinity probe for thromboxane A2/prostaglandin H2 receptors.

P. Halushka, T. Morinelli, N. Hamanaka, 1991, Journal of medicinal chemistry.

Thromboxane A2 receptor antagonists. Synthesis and activities of phenylsulfonamido derivatives

Dale E. Mais, F. Mohamadi, F. Mohamadi, 1991 .

Synthesis of thromboxane receptor antagonists with the potential to radiolabel with 125I

P. Halushka, D. Knapp, N. Hamanaka, 1984 .

Thromboxane A 2 and prostaglandin endoperoxide receptors in platelets and vascular smooth muscle

P. Halushka, D. Knapp, D. Mais, 2005 .

Thromboxane A2 and prostaglandin endoperoxide receptors in platelets and vascular smooth muscle.

P. Halushka, D. Knapp, D. Mais, 1985, Circulation.

A New Synthesis of Ylidenemalononitriles

E. Campaigne, D. Mais, E. M. Yokley, 1975 .

Estrogen Receptor β Activates the Human Retinoic Acid Receptorα -1 Promoter in Response to Tamoxifen and Other Estrogen Receptor Antagonists, but Not in Response to Estrogen

D. Mais, A. Zou, E. Allegretto, 1999 .

Hyperoxia alters platelet disposition of serotonin.

D. Mais, T. Bosin, 1984, Toxicology letters.

Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets.

P. Halushka, P. Kochel, D. Mais, 1985, The Journal of pharmacology and experimental therapeutics.

Solubilization of a thromboxane A2/prostaglandin H2 antagonist binding site from human platelets.

P. Halushka, D. Mais, R. Burch, 1985, Proceedings of the National Academy of Sciences of the United States of America.

Expression, Characterization, and Purification of C-terminally Hexahistidine-tagged Thromboxane A2 Receptors*

K. Schey, P. Halushka, S. Pawate, 1998, The Journal of Biological Chemistry.

Synthesis and characterization of tritium-labeled RU486

Ming-Wei Wang, D. Mais, Lianmei Chen, 1995 .

The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells

D. McDonnell, M. Goldman, Y. Xu, 1994, Molecular and cellular biology.

Reparative changes following oxygen-induced lung injury: effect on serotonin disposition and metabolism.

D. Mais, T. Bosin, P. Lahr, 1983, Toxicology and applied pharmacology.

Hydrodynamic properties of a thromboxane A2/prostaglandin H2 antagonist binding site solubilized from human platelets.

P. Halushka, D. Mais, S. Pepkowitz, 1985, Biochemical and biophysical research communications.

Synthesis and progesterone receptor antagonist activities of 6-aryl benzimidazolones and benzothiazolones.

Z. Zhang, P. Zhang, J. Wrobel, 2001, Bioorganic & medicinal chemistry letters.

Nonsteroidal progesterone receptor antagonists based on 6-thiophenehydroquinolines.

B. Pio, T. K. Jones, D. Mais, 2000, Bioorganic & medicinal chemistry letters.

Biological characterization of a heterodimer-selective retinoid X receptor modulator: potential benefits for the treatment of type 2 diabetes.

M. D. Leibowitz, K. Ogilvie, M. Faul, 2006, Endocrinology.

Potential Benefits for the Treatment of Type 2 Diabetes

M. D. Leibowitz, G. Etgen, C. Broderick, 2005 .

Biochemical and pharmacological activity of arene-fused prostacyclin analogues on human platelets.

P. Fuchs, J. A. Jakubowski, D. Mais, 1994, Prostaglandins.

Structural homologies among thromboxane (TXA2) receptor antagonists: Minimal pharmacophoric requirements for high affinity interaction with TXA2 receptors

D. Robertson, J. A. Jakubowski, D. Mais, 1991 .

Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to guinea-pig platelets.

P. Halushka, D. Mais, M. Garvin, 1986, European journal of pharmacology.

Alpha 1-adrenergic stimulation of arachidonic acid release and metabolism in a rat thyroid cell line. Mediation of cell replication by prostaglandin E2.

A. Luini, D. Corda, J. Axelrod, 1986, The Journal of biological chemistry.

Discovery of novel intracellular receptor modulating drugs

S. Bender, L. Hamann, Michael G. Johnson, 1996, The Journal of Steroid Biochemistry and Molecular Biology.

Quality control of cell-based high-throughput drug screening

Ming-Wei Wang, Zhiyun Zhang, Ni Guan, 2012 .

Platelet and vascular thromboxane A2/prostaglandin H2 receptors. Evidence for different subclasses in the rat.

P. Halushka, D. Mais, A. Masuda, 1991, Biochemical pharmacology.

Difluorothromboxane A2 and stereoisomers: stable derivatives of thromboxane A2 with differential effects on platelets and blood vessels.

P. Halushka, T. Morinelli, J. Fried, 1989, Proceedings of the National Academy of Sciences of the United States of America.

Discovery of orally available tetrahydroquinoline-based glucocorticoid receptor agonists.

Steven L. Roach, J. Miner, D. Mais, 2011, Bioorganic & medicinal chemistry letters.

Tetrahydroquinoline glucocorticoid receptor agonists: discovery of a 3-hydroxyl for improving receptor selectivity.

Steven L. Roach, J. Miner, D. Mais, 2011, Bioorganic & medicinal chemistry letters.

Binding of a thromboxane A2/prostaglandin H2 agonist [3H]U46619 to washed human platelets.

P. Halushka, D. Mais, N. Liel, 1987, Prostaglandins.

Desensitization of platelet thromboxane A2/prostaglandin H2 receptors by the mimetic U46619.

P. Halushka, D. Mais, N. Liel, 1988, Journal of Pharmacology and Experimental Therapeutics.

Photoaffinity receptor antagonist for human platelet thromboxane A2/prostaglandin H2 receptors.

P. Halushka, D. Mais, N. Liel, 1990, Biochemical pharmacology.

Synthesis and Biological Activity of Novel Nonsteroidal Progesterone Receptor Antagonists Based on Cyclocymopol Monomethyl Ether (XIII).

S. Bender, L. Hamann, Ming-Wei Wang, 1996 .

Nonsteroidal human progesterone receptor modulators from the marine alga Cymopolia barbata.

W. Fenical, R. Stein, M. Goldman, 1995, Molecular pharmacology.

Binding of an 125I-labeled thromboxane A2/prostaglandin H2 receptor antagonist to washed canine platelets.

P. Halushka, P. Kochel, D. Mais, 1985, Molecular pharmacology.

High-throughput screening for bioactive components from traditional Chinese medicine.

Meng Zhang, Zhiyun Zhang, Yanhui Zhu, 2010, Combinatorial chemistry & high throughput screening.

Characterization of thromboxane A2/prostaglandin H2 binding sites in guinea pig cardiac membrane preparations.

G. Dorn, G. Dubé, D. Mais, 1994, Journal of Molecular and Cellular Cardiology.

Discovery and biological characterization of a novel series of androgen receptor modulators

H. Su, Ming-Wei Wang, Q. Li, 2008, British journal of pharmacology.

Cyclization of ylidenemalononitriles. VIII. Synthesis of coumarins from o‐methoxybenzylidenemalonitriles

E. Campaigne, D. Mais, 1975 .

CYCLIZATION OF YLIDENEMALONONITRILES PART 8, SYNTHESIS OF COUMARINS FROM O-METHOXYBENZYLIDENEMALONITRILES

E. Campaigne, D. Mais, 1975 .

Benzo[b]thiophene derivatives. XXIII. Derivatives of 5,6‐dihydroxy‐3‐benzo[b] thienylacetic acid

E. Campaigne, D. Mais, E. Homfeld, 1978 .

Thromboxane A2/Prostaglandin H2 Receptors: A Growing Family of Receptor Subtypes

P. Halushka, T. Morinelli, D. Mais, 1991 .

Characterization of a thromboxane A2/prostaglandin H2 receptor in guinea pig lung membranes using a radioiodinated thromboxane mimetic.

G. Dubé, D. Mais, C. Williams, 1991, Molecular pharmacology.

Human erythroleukemia cells express functional thromboxane A2/prostaglandin H2 receptors.

P. Halushka, C. Carr, D. Mais, 1989, The Journal of pharmacology and experimental therapeutics.

Photoaffinity labelling of the human platelet thromboxane A2/prostaglandin H2 receptor.

C. Yoakim, J. Rokach, J. Gillard, 1989, Biochimica et biophysica acta.

Further studies on the effects of epimers of thromboxane A2 antagonists on platelets and veins.

P. Halushka, N. Hamanaka, D. Mais, 1985, European journal of pharmacology.

A role for serotonin in alpha-naphthylthiourea-induced pulmonary edema.

D. Mais, T. Bosin, 1984, Toxicology and applied pharmacology.

Localization of [125I]SAP-N3 binding in the human platelet thromboxane A2/prostaglandin H2 receptor by proteolytic cleavage analysis.

D. Mais, T. True, 1994, European Journal of Pharmacology.

Photometric Survey for Asynchronous Binary Asteroids

P. Pravec, B. Warner, J. Foote, 2005 .

Adventures in Interferometry

R. Stencel, B. Kloppenborg, D. Mais, 2008 .

Decrease in agonist affinity for human platelet thromboxane A2/prostaglandin H2 receptors induced by a platelet-derived supernatant.

G. Dorn, P. Halushka, P. Kochel, 1987, Biochemical pharmacology.

Photoaffinity labelling of a thromboxane A2/prostaglandin H2 antagonist binding site in human platelets.

P. Halushka, D. Knapp, D. Mais, 1986, Biochemical and biophysical research communications.

Thromboxane A 2 Receptors: Characterization and Regulation

P. Halushka, T. Morinelli, D. Mais, 1993 .

A novel approach for the study of thromboxane A2 and prostaglandin H2 receptors using an 125I-labeled ligand.

C. Dollery, I. Blair, P. Halushka, 1985, Biochemical pharmacology.

Identification of a putative thromboxane A2/prostaglandin H2 receptor in human platelet membranes.

P. Halushka, D. Mais, R. Burch, 1986, The Journal of biological chemistry.

Oxygen-induced lung toxicity: effect on serotonin disposition and metabolism.

D. Mais, T. Bosin, P. Lahr, 1982, Toxicology and applied pharmacology.

Expedient synthesis and biochemical properties of an [125I]-labeled analogue of glyburide, a radioligand for ATP-inhibited potassium channels.

J. Krushinski, D. Thompson, D. Gehlert, 1990, Journal of Medicinal Chemistry.

Thromboxane and prostacyclin receptors.

P. Halushka, T. Morinelli, D. Mais, 1989, Progress in clinical and biological research.

The Society for Astronomical Sciences 21st Annual Symposium on Telescope Science

Brian D. Warner, Robert K. Buchleim, Jerry Foote, 2002 .

A selective peroxisome proliferator-activated receptor-gamma (PPARgamma) modulator blocks adipocyte differentiation but stimulates glucose uptake in 3T3-L1 adipocytes.

J. Bilakovics, J. Paterniti, D. Mais, 2000, Molecular endocrinology.

Synthesis and Characterization of a Highly Potent and Selective Isotopically Labeled Retinoic Acid Receptor Ligand, ALRT1550.

K. Flatten, M. Boehm, A. Nadzan, 1998, The Journal of organic chemistry.

Synthesis and biochemical properties of an 125I-labelled ryanodine derivative.

D. Mais, A. M. Watanabe, N. Bowling, 1992, Biochemical and biophysical research communications.